Satsuma Pharmaceuticals

/Satsuma Pharmaceuticals

We are a clinical-stage biopharmaceutical company developing a novel therapeutic product for the acute treatment of migraine.


Price Range
$14.00 - $16.00

Final Shares

Anticipated Date
September 13, 2019


This offering is no longer available

To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange